Uranium Royalty Corp. (UROY) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-03, Uranium Royalty Corp. (NASDAQ: UROY) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $3.35 (-3.46% 1D, market cap $1.26B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, UROY ranks #570 in composite RQD confidence.
Within the Financials sector (Investment Bankers/Brokers/Service), UROY carries a Roarable D+ (53/100 RQD), trailing P/E of 32.5x, gross margin of —, and ROIC of —. By comparison, TOP (TOP Financial Group Limited (Class A)) holds a D grade (50/100 RQD, P/E N/A, ROIC —, cap $1.37B) and MUA (Blackrock MuniAssets Fund Inc) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $1.46B). Among the 5-stock peer group, UROY leads on earnings multiple (32.5x) while UROY leads on capital efficiency (— ROIC).
Per UROY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-04-30, CIK 0002143673), Uranium Royalty Corp. generated $0 in revenue, $40.2M in net income, and $178.5M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 4.5% FCF Margin ($178.5M FCF) & 52% Gross Margin
SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-1.80% YoY Shares)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
While UROY currently carries a cautious 53/100 (D+) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Company leadership has skin in the game with net positive insider conviction.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.04) and Max Pain ($3.52) forces dealer call-delta covering toward $5.80.
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Uranium Royalty Corp. (UROY) dropped -3.46% to $3.35, trading at 27% of its 52-week range ($2.56 – $5.52). Stretched risk/reward at 33x P/E (steady margins) under elevated 10-year interest-rate pressure.
Yahoo Finance report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Investing.com report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
HC Wainwright & Co. analyst Heiko F. Ihle reiterates Uranium Royalty (NASDAQ:UROY) with a Buy and maintains $4.5 price target.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on UROY today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for UROY. Explore sector supply chains on /butterfly.
Across 1096 tracked Financials securities in the Roarable RQD universe, Uranium Royalty Corp. (UROY) ranks #570 by composite RQD confidence (53/100, grade D+) and #513 by equity capitalization ($1.26B). Within this direct 5-issuer industry benchmark cohort, UROY leads on earnings valuation at 32.5x trailing P/E, while UROY leads on capital efficiency and profitability with — ROIC and — gross margin. UROY currently leads its immediate peer cohort in composite quantitative strength at 53/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| UROY
ACTIVE
Uranium Royalty Corp. | D+ | 53/100 | 32.5x | — | — | -3.46% | $1.26B | Benchmark Subject |
| TOP TOP Financial Group Limited (Class A) | D | 50/100 | — | — | — | -22.42% | $1.37B | /top-vs-uroy → |
| MUA Blackrock MuniAssets Fund Inc | D | 47/100 | — | — | — | +0.20% | $1.46B | /mua-vs-uroy → |
| BKT BlackRock Income Trust Inc. | D | 46/100 | — | — | — | -0.20% | $1.47B | /bkt-vs-uroy → |
| MUC Blackrock MuniHoldings California Quality Fund Inc. | D | 47/100 | — | — | — | +0.60% | $1.51B | /muc-vs-uroy → |
In its most recent audited fiscal period (FY2025, filed 2026-04-30), Uranium Royalty Corp. (UROY) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $40.2M, operating cash flow of $178.5M, and free cash flow of $178.5M (+1285.0% YoY). On the balance sheet, UROY closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-04-30 | $0 | $40.2M | $178.5M | $178.5M | — | — |
| FY2024 (FY) | 2025-04-30 | $0 | -$4.5M | -$15.1M | -$15.1M | — | — |
| FY2023 (FY) | 2024-04-30 | $0 | $13.7M | -$76.4M | -$76.4M | — | — |
As of 2026-11-03, Uranium Royalty Corp. (NASDAQ: UROY) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $3.35 (-3.46% 1D, market cap $1.26B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 14/20. Across 1096 tracked Financials issuers, UROY ranks #570 in composite RQD confidence.
Within the Financials sector (Investment Bankers/Brokers/Service), UROY carries a Roarable D+ (53/100 RQD), trailing P/E of 32.5x, gross margin of —, and ROIC of —. By comparison, TOP (TOP Financial Group Limited (Class A)) holds a D grade (50/100 RQD, P/E N/A, ROIC —, cap $1.37B) and MUA (Blackrock MuniAssets Fund Inc) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $1.46B). Among the 5-stock peer group, UROY leads on earnings multiple (32.5x) while UROY leads on capital efficiency (— ROIC).
Per UROY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-04-30, CIK 0002143673), Uranium Royalty Corp. generated $0 in revenue, $40.2M in net income, and $178.5M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
UROY last traded at $3.35 (-3.46% on volume of 2,975,496 shares), positioning the stock -17.08% below its 50-day simple moving average ($4.04) and -10.67% below its 200-day simple moving average ($3.75). Across its 52-week range of $2.56 to $5.52, UROY sits at the 26.7% percentile with a 14-day RSI of 38.1 (NEUTRAL RANGE) and an implied next-earnings move of ±9.6% ($3.03 to $3.67).
Why UROY Stock dropped -3.46% Today — RQD Quant Desk Flash. Stretched risk/reward at 33x P/E (steady margins) under elevated 10-year interest-rate pressure.
Per the Roarable RQD rating, UROY scores 54 out of 100, a letter grade of D+, with the verdict "Roarable Sell — Weak Fundamentals / Trim." The fundamental cash engine pillar scores 14 of 20, with ROIC at 0% and an FCF yield of 13.63%, which points to a cash-generation profile that is more meaningful than its accounting returns. The whale 13F flow pillar scores 4 of 20, indicating weak institutional accumulation and options positioning in the source data. The insider conviction pillar scores 14 of 20, reflecting SEC Form 4 and Congressional PTR cluster flow. The macro regime fit pillar scores 9 of 20, with a beta of 1.0 and sector sensitivity as the stated driver. The forensic balance sheet pillar scores 13 of 20, supported by an Altman Z-Score of 2.5, a Piotroski F-Score of 5/9, and a Debt/Equity ratio of 0.5.
For a prospective investor evaluating the stock today, the upside case rests mainly on the free-cash-flow yield and the FY 2025 FCF figure of $178.5M, which stands far above reported net income. The valuation tradeoff is significant: per the market data, the P/E (TTM) is 32.5 and EV/EBITDA is 27.1 against EPS (TTM) of 0.11, meaning the price embeds expectations well beyond current reported earnings. The low whale-flow score and the weak macro-fit score suggest limited institutional tailwind and above-market sensitivity. These are analytical observations from the rating framework, not a personalized recommendation.
Uranium Royalty Corp. (UROY) is a NASDAQ-listed company classified in the Financials sector and the Investment Bankers/Brokers/Service industry, per the profile. Not available in source data for product lines, customer base, or revenue model detail. The reported revenue figures are $0.0M across all listed periods, per the SEC financials. Not available in source data for how the company makes money beyond the reported net income and FCF figures.
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $0.0M | $48.3M | $40.2M | N/A | $178.5M | N/A | N/A |
| FY 2024 | $0.0M | $-3.4M | $-4.5M | N/A | $-15.1M | N/A | N/A |
| FY 2023 | $0.0M | $5.1M | $13.7M | N/A | $-76.4M | N/A | N/A |
Per the SEC financials, reported revenue is $0.0M in each period, while operating income was $48.3M in FY 2025 after losses in FY 2024 and positive results in FY 2023. Market data lists gross, operating, and net margins as 0%, and ROIC as 0%, so profitability cannot be assessed from margin figures in the source. Per the RQD forensic pillar, the Altman Z-Score is 2.5, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. Cash and debt balances are not available in source data.
Per <recent_news_and_catalysts>, the most recent items are headlines covering an equity shelf capacity expansion of US$916 Million, a note that the stock "Looks Fully Priced After A 30% Gain," an H.C. Wainwright reiteration of a buy rating, a TradingView estimates page, a MarketBeat consensus target item citing $4.12, and a Simply Wall St piece on whether the shelf registration changes the bull case. The shelf-expansion headline is the most material risk watch item, as it signals potential equity dilution capacity. The "fully priced" headline and the $4.12 consensus figure frame the valuation debate. The Butterfly Supply-Chain Graph reports no proprietary signals and no supply-chain links, so no proprietary signal read-through is available.
Per the Butterfly Supply-Chain Graph, supply chain status is NONE and no butterfly links are present. Not available in source data for upstream or downstream dependencies, sector correlations beyond the Financials classification, or second-order bottlenecks. A prospective investor should note that the absence of mapped links means ripple effects cannot be traced from the source data.
Real-time company headlines, analyst actions, and sector developments for Uranium Royalty Corp. (UROY) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Investing.com report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Uranium Royalty Corp. (UROY) market action, institutional positioning, and fundamental catalysts.
Welcome to the UROY (Uranium Royalty Corp.) Roar Pit. Current RQD Composite is 54/100 (Roarable Sell — Weak Fundamentals / Trim) in Investment Bankers/Brokers/Service. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.5x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on UROY, but look at what you are paying: 32.5x trailing P/E with tightening sector spreads. Unless Uranium Royalty Corp. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on UROY, the market is fixating on short-term headline noise in Investment Bankers/Brokers/Service and ignoring the balance sheet and cash flow trajectory. At $3.47 (52-wk range $2.56 - $5.52), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).